An extended set of yeast-based functional assays accurately identifies human disease mutations

Citations Over Time

Abstract

We can now routinely identify coding variants within individual human genomes. A pressing challenge is to determine which variants disrupt the function of disease-associated genes. Both experimental and computational methods exist to predict pathogenicity of human genetic variation. However, a systematic performance comparison between them has been lacking. Therefore, we developed and exploited a panel of 26 yeast-based functional complementation assays to measure the impact of 179 variants (101 disease- and 78 non-disease-associated variants) from 22 human disease genes. Using the resulting reference standard, we show that experimental functional assays in a 1-billion-year diverged model organism can identify pathogenic alleles with significantly higher precision and specificity than current computational methods.

Related Papers

• → The Human Genome Diversity Project: past, present and future(2005)413 cited
• → An Incomplete Understanding of Human Genetic Variation(2016)98 cited
• → The future of model organisms in human disease research(2011)81 cited
• → Mouse as a Model for Human Diseases(2006)1 cited
• [The mouse model and human disease].(2001)